IMHA in Dogs: Causes, Symptoms, and Treatment

Name: IMHA in Dogs: Causes, Symptoms, and Treatment
Creator: Dr. Zubair Khalid

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-10-03

Immune-mediated hemolytic anemia (IMHA) in dogs happens when the immune system mistakes a dog's own red blood cells for invaders and destroys them faster than the body can replace them. The most common IMHA in dogs causes include an underlying trigger such as infection, cancer, or a drug reaction, though many cases have no identifiable cause at all. It is a serious, sometimes life-threatening condition that needs prompt veterinary care.

This article is educational and is not a substitute for veterinary diagnosis or treatment.

Quick Answer

IMHA is the leading cause of hemolytic anemia in dogs, meaning red blood cell destruction from a non-inherited cause [1].
Roughly one third of dogs with IMHA have an identifiable trigger such as toxins, infection, cancer, or inflammation, and the rest are classified as non-associative (no clear trigger) [2].
Common signs include weakness, pale gums, yellow-tinged skin or eyes, dark urine, and rapid breathing.
Diagnosis relies on blood tests, and treatment usually starts with immunosuppressive steroids, sometimes plus blood transfusions.
IMHA is not contagious to other pets or to people. It is an immune system problem, not an infection that spreads.

What Is IMHA in Dogs?

Red blood cells carry oxygen. In IMHA, the immune system produces antibodies that attach to those cells and mark them for destruction. The spleen and liver then remove them from circulation, and the bone marrow cannot keep up with the loss.

The result is anemia, which means too few red blood cells to deliver enough oxygen to the body. When red blood cells break down, they release hemoglobin that gets processed into bilirubin. High bilirubin is what turns gums, skin, and the whites of the eyes yellow, a condition called jaundice.

Veterinarians divide IMHA into two broad groups. Primary (non-associative) IMHA has no identifiable underlying trigger. Secondary (associative) IMHA develops because of another condition or exposure that sets off the immune attack.

IMHA in Dogs Symptoms: What Owners Notice First

Signs often come on quickly, over a few days, though some dogs decline more slowly. Watch for:

Weakness, lethargy, or reluctance to walk or climb stairs
Pale, white, or yellow gums and eye whites
Fast or labored breathing, even at rest
Dark yellow, orange, or brown urine
Reduced appetite, vomiting, or diarrhea
Collapse or fainting

Some dogs develop neurologic signs. In one study of 81 dogs with non-associative IMHA and high bilirubin, 20 percent developed signs such as stupor, inability to walk on all four legs, or generalized seizures [3]. This is a serious complication tied to how high bilirubin climbs.

If your dog has pale gums, trouble breathing, or collapses, treat it as an emergency. Do not wait for a routine appointment.

IMHA in Dogs Causes and Risk Factors

This is the part owners ask about most. The honest answer is that many cases have no single clear cause. Here is what research shows.

Identifiable triggers

In a study of 222 dogs with IMHA in the United Kingdom and Ireland, 33 percent had an associative cause [2]. Those included:

Toxic exposures (11 percent)
Infections (8 percent)
Cancer (7 percent)
Non-infectious inflammatory conditions (6 percent)

The same study found that associative IMHA became more likely as dogs got older [2]. Another 46 percent of dogs had a finding that was probably incidental, and 21 percent had no relevant findings at all [2].

Infection as a trigger

Certain blood parasites are well-known triggers of secondary IMHA. Babesia gibsoni is one example. In a study of 55 dogs with IMHA, 29 had natural B. gibsoni infection confirmed by PCR, and those dogs had poorer survival than dogs with primary IMHA [4]. This is one reason your veterinarian may recommend specific testing for tick-borne and blood-borne organisms.

Vaccination and timing

Vaccination has been studied as a possible trigger. In a large case-control study, 11.9 percent of dogs with non-associative IMHA had been vaccinated within 30 days of disease onset, compared with 6.1 percent of control dogs [5]. That is a statistical association, not proof that vaccines cause IMHA. The authors noted that affected dogs were more likely to have received a leptospirosis vaccine in their last dose [5]. Talk with your veterinarian about your dog's individual risk if you have concerns.

Pregnancy and drugs

IMHA has been reported in a pregnant dog, where it was possibly secondary to pregnancy or to a recent course of antibiotics [6]. This is a single case, so it does not prove cause. Still, it shows that pregnancy and medication exposure can coincide with IMHA onset.

Is IMHA hereditary or contagious?

IMHA is not contagious. Your other pets and your family cannot catch it from an affected dog. It is an immune system disorder, not an infection.

Some breeds appear more often in IMHA case populations, and immune-mediated diseases can run in families. That said, published research do not establish a specific inherited gene for IMHA. If you are choosing a puppy or planning a breeding, ask your veterinarian about breed predispositions and health screening.

How Veterinarians Diagnose IMHA in Dogs

Diagnosis is not a single test. Your veterinarian builds a picture from several pieces.

Physical exam and history

Your vet will check gum color, heart rate, breathing, and hydration. They will ask about recent illness, tick exposure, travel, medications, and vaccinations.

Blood work

A complete blood count shows how anemic your dog is and whether red blood cells are being regenerated. Biochemistry panels check organ function. Bilirubin is measured because it rises when red blood cells break down.

Urine testing

Urinalysis adds useful information. In a study of 21 dogs with suspected IMHA, urinary bilirubin was increased compared with controls, and the urinary protein-to-creatinine ratio was elevated and correlated with how severe the anemia was [1]. Your vet may use these markers to gauge severity and prognosis.

Screening for underlying causes

Because a third of cases have a trigger, your vet may recommend imaging, infectious disease testing, or other screening [2]. Finding and treating the trigger can improve the odds.

Ruling out other causes

Not every anemia is IMHA. Your vet will consider blood loss, bone marrow disease, and inherited red blood cell disorders. This is where a veterinary internist may become involved.

IMHA in Dogs Treatment Options

Treatment has two goals: stop the immune attack and support your dog through the crisis.

Immunosuppressive therapy

Corticosteroids are the backbone of treatment. In one study, dogs received prednisolone at 1 mg/kg twice daily by mouth, or dexamethasone sodium phosphate at 0.2 mg/kg once daily intravenously [4]. These are published study doses, not a prescription for your dog. Your veterinarian calculates the exact dose and taper based on your dog's weight, test results, and response.

Dogs with an identified infection also need treatment for that infection. In the Babesia study, dogs received antibabesial treatment including imidocarb dipropionate at 6.6 mg/kg intramuscularly at two-week intervals, plus doxycycline [4].

Blood transfusions

Severely anemic dogs often need transfusions to stabilize them while immunosuppression takes effect. In one reported case, a pregnant dog was hospitalized for five days and received multiple transfusions along with steroids [6].

Supportive care

Hospitalization, oxygen, intravenous fluids, anti-nausea medication, and monitoring for blood clots are common. Your vet will also watch kidney function, since renal changes are seen in IMHA patients [1].

When steroids do not work

About 15 to 30 percent of dogs fail corticosteroid-based therapy, and these cases carry high early mortality [7]. For steroid-refractory IMHA, intravenous allogeneic mesenchymal stem cell therapy has been studied. In a follow-up study of 137 dogs, median survival was 1,695 days (about 4.6 years) in the primary cohort, and estimated one-year survival was 56.9 percent [7]. This is a specialized option, so ask your veterinarian whether a referral is appropriate.

A note on pregnancy

Treating IMHA during pregnancy is possible. In one case, a dog received steroids, transfusions, and progesterone to maintain her pregnancy, then delivered four healthy puppies and was weaned off steroids after six weeks [6].

Situation	Typical first step	What to expect
Suspected IMHA, stable	Blood work, urinalysis, exam	Same-day diagnostics, possible hospitalization
Severe anemia or collapse	Emergency visit, transfusion	Intensive care, monitoring for complications
Confirmed IMHA	Steroids plus trigger treatment	Weeks to months of medication and rechecks
Steroid-refractory	Specialist referral	Advanced options such as stem cell therapy [7]

Recovery, Outlook, and Long-Term Management

Recovery is a marathon, not a sprint. Many dogs need months of medication, and relapses happen.

Your veterinarian will recheck blood counts regularly and taper steroids slowly. Tapering too fast can trigger a relapse. Report any return of weakness, pale gums, or dark urine right away.

Survival varies widely. Dogs with a concurrent Babesia gibsoni infection had worse outcomes than dogs with primary IMHA [4]. Dogs with very high bilirubin and neurologic signs face added risk [3]. On the other hand, many dogs do well with early, aggressive treatment.

At home, focus on:

Giving medications exactly as prescribed, at the same times each day
Keeping recheck appointments, even when your dog looks better
Limiting stress and strenuous activity during recovery
Watching for side effects of steroids, such as increased thirst, appetite, and urination

If your dog develops head tilting, circling, or balance problems during recovery, those can overlap with other neurologic and ear conditions. Our guides on dog inner ear infection symptoms treatment and inner ear infection symptoms in dogs explain how vets sort out those signs. For dogs with back or neck pain, see our article on ivdd in dogs.

Prevention

There is no vaccine or diet that prevents IMHA. You can lower some risks:

Use tick prevention year-round and check your dog after hikes or time in tall grass.
Ask your vet about testing for blood parasites if your dog has been exposed.
Keep vaccinations current, and discuss timing and vaccine choices with your veterinarian, especially if your dog has had an immune-mediated reaction before.
Treat infections and inflammatory conditions promptly.
Tell your vet about every medication and supplement your dog takes.

Limitations and When to Contact a Veterinarian

No article can replace an exam and blood work on your specific dog. Individual cases need a veterinarian who can see your pet, run tests, and adjust treatment.

Contact your veterinarian the same day if you notice:

Pale, white, or yellow gums
Dark or orange urine
Sudden weakness or reluctance to move
Fast breathing at rest
Vomiting or loss of appetite that lasts more than a day

Go to an emergency clinic now if your dog:

Collapses or cannot stand
Struggles to breathe
Has a seizure or becomes unresponsive
Has gums that look white or blue

Schedule a routine visit if your dog is stable but you have noticed a gradual change in energy, appetite, or gum color over several days.

Frequently Asked Questions

Is IMHA in dogs contagious to other pets?

No. IMHA is an immune system disorder, not an infection, so it cannot spread to other dogs, cats, or people. If an underlying infection such as a blood parasite is involved, that organism may have its own transmission route, so ask your veterinarian about testing other pets if exposure is possible.

Can IMHA in dogs be cured?

Many dogs go into remission with treatment, but IMHA is managed instead of simply cured. Some dogs need medication for months, and relapses can occur, so regular blood work and slow medication tapering matter. Your veterinarian will guide how long treatment continues based on your dog's response.

Is IMHA hereditary in dogs?

The available research does not identify a specific inherited gene for IMHA. Some breeds appear more often in case populations, and immune-mediated conditions can cluster in families, so tell your veterinarian about your dog's breed and family history. If you plan to breed, discuss health screening with your vet first.

How long does IMHA treatment last in dogs?

Treatment usually runs for several months, with steroids tapered gradually based on blood test results. One reported case was weaned off steroids after six weeks [6], but that is a single case and not a typical timeline. Your dog's course depends on severity, response, and whether a trigger was found.

Can a dog with IMHA live a normal life?

Many dogs return to normal activity once anemia resolves and medications are reduced. Long-term survival varies, and dogs with concurrent infections tend to do worse [4]. With close monitoring and good communication with your veterinary team, many dogs enjoy a good quality of life for years.

References

Assessment of Renal Function and Bilirubin Measurement in Urine as Prognostic Value in Immune-Mediated Hemolytic Anemia in Dogs. Anais da Academia Brasileira de Ciencias, 2026.
Multicenter, Retrospective Determination of the Clinical Utility of Screening Tests in Dogs With Immune-Mediated Hemolytic Anemia in the United Kingdom and Ireland. Journal of veterinary internal medicine, 2025.
Hyperbilirubinemia and neurologic signs in dogs with non-associative immune-mediated hemolytic anemia: 81 cases (2015-2024). Journal of veterinary internal medicine, 2026.
Concurrent Babesia gibsoni infection as a negative prognostics indicator of survival in dogs diagnosed with immune-mediated hemolytic anemia: A prospective cohort study. Topics in companion animal medicine, 2026.
Investigation and systematic review of temporal associations between vaccination and onset of immune-mediated hemolytic anemia or thrombocytopenia in dogs. Journal of veterinary internal medicine, 2026.
Successful treatment of immune-mediated hemolytic anemia in a pregnant dog: a case report. Frontiers in veterinary science, 2026.
Long-Term Survival, Illness Severity, and Time-to-Treatment Analysis in Dogs with Immune-Mediated Hemolytic Anemia Following Intravenous Allogeneic Mesenchymal Stem Cell Therapy: A Multicohort Follow-Up Study. Stem cells and development, 2026.